Paper Alert: Anti-Inflammatory Blocks Aβ Deposition in AD Mice
first clinical trial of CNI-1493 as an AD drug.—Esther Landhuis None
379 RESULTS
You searched Esther
Sort By:
first clinical trial of CNI-1493 as an AD drug.—Esther Landhuis None
hypothesis of AD’ are much more closely related than it initially appeared.”—Esther Landhuis None
neuronal loss, will be key to sorting out the role of inflammation in AD.—Esther Landhuis None
next month at the ICAD meeting.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=1852
mimic Aβ40 in its ability to prevent Aβ42 aggregation.—Esther Landhuis None
patients.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1842 Alzheimer's Disease Proteostasis
having a silent heart attack.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1832
determine whether something was a real effect. That is where AD needs to go.”—Esther Landhuis None
said.—Esther Landhuis Esther Landhuis is a science writer in Dublin, California. None
Take a look at his vaccination proposal, and join the discussion.—Esther Landhuis. Esther Landhuis is
his talk title, that “in the beginning…there was amyloid.”—Esther Landhuis. This story concludes our
synaptic activity.—Esther Landhuis. This is Part 3 of a four-part series. See also Part 1, Part 2. None
intraventrically can produce effects comparable to direct injections into the hippocampus.—Esther Landhuis Esther
shunted, the only one who didn’t improve was the one who had AD pathology, as well.—Esther Landhuis. See
neuropsychological tests.—Esther Landhuis. This is Part 1 of a four-part series. See Part 2. None